Clivatuzumab biosimilar antibody

• Catalog Number: orb1140941
• Category: Antibodies
• Description: Yttrium (90Y) clivatuzumab tetraxetan (trade name hPAM4-Cide) is a humanized monoclonal antibody-drug conjugate designed for the treatment of pancreatic cancer. The antibody part, clivatuzumab (targeted at MUC1), is conjugated with tetraxetan, a chelator for yttrium-90, a radioisotope which destroys the tumour cells.
• Isotype: IgG1 Kappa
• Concentration:

  1mg/ml

• Purity: ≥95%
• Conjugation: Unconjugated
• Alternative names: hPAM4, hPAM4 IgG-DOTA, hPAM4-DOTA
• Note: For research use only
• Expiration Date: 12 months from date of receipt.